by pmloper | Apr 6, 2026 | CONCI Updates
GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound) have transformed the landscape of obesity medicine. For many patients, these drugs deliver results that were once only achievable through bariatric surgery, with 15% to 25% of total body...
by pmloper | Dec 22, 2025 | CONCI Updates
Obesity is a chronic disease and has been identified as such since the World Health Organization (WHO) declared so in 1997. Now, nearly three decades later, the WHO has taken a landmark step forward in addressing this global health challenge by issuing the first-ever...
by pmloper | Oct 29, 2025 | Research
If you’ve struggled with weight loss on your own, you’re not alone. Understanding the difference between medical weight loss and losing weight independently can help you make an informed decision about which approach is right for you. We’re more than...
